Trial Profile
Continuous administration trial of PEGASUS-PC Study (Phase2/3 study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Elpamotide (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Sponsors OncoTherapy Science